How atomoxetine affects motivation in healthy adults
Treatments studied
Part of Brain & nervous system clinical trials.
This study tests whether a medication called atomoxetine (commonly used for ADHD) can affect motivation in healthy adults. It involves taking the medication and completing tasks to measure motivation, which could help understand how this drug works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old
- You should be in good general health
- You cannot have been diagnosed with ADHD or be waiting for an ADHD assessment
- You cannot have a current or past serious mental health condition like bipolar disorder, schizophrenia, or PTSD, or problems with alcohol or drug abuse
- You must not have a history of heart problems, high blood pressure, or be taking heart or blood pressure medication
- You must not be taking any central nervous system medications (like antidepressants or stimulants) in the past 6 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a common antidepressant (escitalopram) affects motivation and effort in healthy adults. It aims to understand how the drug works in the brain, which could help improve treatments for depression.
This study tests a medicine called methylphenidate (often used for ADHD) to see if it helps reduce apathy—feelings of lack of motivation or interest—in people with Parkinson's disease. If it works, it could improve your quality of life and daily functioning.
This study tests a digital therapy to improve apathy (feeling unmotivated or “checked out”) in people age 60+ who have depression. It also uses brain imaging (MRI) and questionnaires to see whether the treatment helps brain function linked to motivation.
This study tests if combining a type of brain stimulation (repetitive TMS) with a medication (methylphenidate, commonly used for ADHD) can improve apathy in people with dementia. If you have Alzheimer's or mixed dementia and struggle with low motivation, this trial may help you.
This study looks at “apathy,” or reduced motivation/interest, in people with schizophrenia or depression. It may help researchers understand what drives apathy and how to measure it in a clearer, more complete way.
This study tests whether a treatment (atomoxetine or metformin) can help people with Alzheimer's disease maintain an improved state for at least 18 months. It may help you or a loved one stabilize symptoms and slow disease progression.
Hear when a new Apathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.